13F Data
13F filer · CIK 1622627

Rosalind Advisors, Inc.

TORONTO, A6 · filing since Q4 2023 · last filing Aug 14, 2026
Reported value
$269.2M
$-122.9M vs prior
Positions
35
New / sold out
9 / 12
Added / reduced
7 / 11
Turnover
7.6%
buys $25.2M · sells $185.6M
Top-10 weight
74.0%

Biggest buys vs Q1 2026

ChangeSecurityShares changeChange %Est. trade value
AddedVERASTEM INC+1,848,034+86.4%+$7.1M
AddedFENNEC PHARMACEUTICALS INC+279,800+9.6%+$3.0M
AddedCYBIN INC+425,000+27.7%+$2.8M
NewABIVAX SA+20,869–+$2.8M
NewSELLAS LIFE SCIENCES GROUP INCPUT+568,700–+$2.3M
AddedTALPHERA INC+1,815,585+54.1%+$1.9M
AddedREGENTIS BIOMATERIALS LTD+450,175+179.0%+$1.6M
AddedNEURAXIS INC+221,917+77.6%+$1.3M
NewSPRUCE BIOSCIENCES INC+20,000–+$1.1M
NewPEPGEN INC+350,000–+$630.0K
6 more rows. Subscribe for $29/month to see every row, download the data and use the API.

Biggest sells vs Q1 2026

ChangeSecurityShares changeChange %Est. trade value
Sold outINVESCO QQQ TRPUT-250,000-100.0%$-144.3M
Sold outCG ONCOLOGY INC-100,000-100.0%$-6.8M
ReducedVAXCYTE INC-90,000-31.0%$-5.2M
Sold outVIRIDIAN THERAPEUTICS INC-250,401-100.0%$-4.9M
ReducedCELLDEX THERAPEUTICS INC-130,000-39.4%$-4.8M
Sold outREPLIMUNE GROUP INCCALL-1,275,600-100.0%$-2.7M
ReducedXERIS BIOPHARMA HOLDINGS INC-322,719-10.0%$-2.6M
Sold outDEFINIUM THERAPEUTICS INC-125,000-100.0%$-2.4M
ReducedBIOCRYST PHARMACEUTICALS INC-201,553-21.8%$-2.0M
Sold outLIPOCINE INC-221,616-100.0%$-1.8M
13 more rows. Subscribe for $29/month to see every row, download the data and use the API.

Estimated trade value = change in shares × this quarter's implied price. 13F filings show quarter-end positions, not individual trades.

Reported value by quarter

Q4 2023: $121.4MQ1 2024: $107.0MQ2 2024: $130.0MQ3 2024: $156.2MQ4 2024: $195.6MQ1 2025: $205.6MQ2 2025: $210.9MQ3 2025: $441.1MQ4 2025: $1.2BQ1 2026: $392.1MQ2 2026: $269.2M
Q4 2023Q2 2026

Holdings · Q2 2026

#SecuritySharesValueWeight
1DELCATH SYSTEMS, INC.COM NEW3,300,389$41.6M15.44%
2FENNEC PHARMACEUTICALS INCCOM3,188,001$34.3M12.73%
3XERIS BIOPHARMA HOLDINGS INCCOM2,908,981$23.0M8.56%
4SAVARA INCCOM3,178,121$19.6M7.27%
5VERASTEM INCCOM NEW3,986,509$15.2M5.66%
6X4 PHARMACEUTICALS INCCOM NEW3,214,766$15.0M5.58%
7EYEPOINT PHARMACEUTICALS INCCOM NEW988,230$14.1M5.25%
8CYBIN INCCOM NEW1,956,814$12.9M4.80%
9VOR BIOPHARMA INCCOM NEW648,600$11.9M4.44%
10VAXCYTE INCCOM200,000$11.6M4.32%
25 more rows. Subscribe for $29/month to see every row, download the data and use the API.